This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labthavikul, P.
Right arrow Articles by Bradford, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labthavikul, P.
Right arrow Articles by Bradford, P. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2003, p. 3967-3969, Vol. 47, No. 12
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.12.3967-3969.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

In Vitro Activity of Tigecycline against Staphylococcus epidermidis Growing in an Adherent-Cell Biofilm Model

Pornpen Labthavikul, Peter J. Petersen,* and Patricia A. Bradford

Infectious Disease Research, Wyeth, Pearl River, New York 10965

Received 19 February 2003/ Returned for modification 3 July 2003/ Accepted 30 August 2003

The activity of tigecycline against Staphylococcus epidermidis growing in an in vitro adherent-cell biofilm model was determined. Tigecycline minimum bactericidal concentrations (MBCs) ranged from 1 to 8 µg/ml for S. epidermidis growing in a biofilm of adherent cells, compared to MBCs of 0.12 to >32 µg/ml for freely growing cells. The killing activity of tigecycline against the adherent bacteria was at least fourfold better than that of vancomycin and daptomycin.


* Corresponding author. Mailing address: Infectious Disease Research, Wyeth Research, Bldg. 200, Rm. 3301, 401 N. Middletown Rd., Pearl River, NY 10965. Phone: (845) 602-3070. Fax: (845) 602-5671. E-mail: petersp{at}wyeth.com.


Antimicrobial Agents and Chemotherapy, December 2003, p. 3967-3969, Vol. 47, No. 12
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.12.3967-3969.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Martinez-Pastor, J. C., Munoz-Mahamud, E., Vilchez, F., Garcia-Ramiro, S., Bori, G., Sierra, J., Martinez, J. A., Font, L., Mensa, J., Soriano, A. (2009). Outcome of Acute Prosthetic Joint Infections Due to Gram-Negative Bacilli Treated with Open Debridement and Retention of the Prosthesis. Antimicrob. Agents Chemother. 53: 4772-4777 [Abstract] [Full Text]  
  • Vaudaux, P., Fleury, B., Gjinovci, A., Huggler, E., Tangomo-Bento, M., Lew, D. P. (2009). Comparison of Tigecycline and Vancomycin for Treatment of Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53: 3150-3152 [Abstract] [Full Text]  
  • Flemming, K., Klingenberg, C., Cavanagh, J. P., Sletteng, M., Stensen, W., Svendsen, J. S., Flaegstad, T. (2009). High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms. J Antimicrob Chemother 63: 136-145 [Abstract] [Full Text]  
  • Mascio, C. T. M., Alder, J. D., Silverman, J. A. (2007). Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells. Antimicrob. Agents Chemother. 51: 4255-4260 [Abstract] [Full Text]  
  • Ghiselli, R., Giacometti, A., Cirioni, O., Mocchegiani, F., Silvestri, C., Orlando, F., Kamysz, W., Licci, A., Nadolski, P., Della Vittoria, A., Lukasiak, J., Scalise, G., Saba, V. (2007). Pretreatment With the Protegrin IB-367 Affects Gram-Positive Biofilm and Enhances the Therapeutic Efficacy of Linezolid in Animal Models of Central Venous Catheter Infection. JPEN J Parenter Enteral Nutr 31: 463-468 [Abstract] [Full Text]  
  • Raad, I., Hanna, H., Jiang, Y., Dvorak, T., Reitzel, R., Chaiban, G., Sherertz, R., Hachem, R. (2007). Comparative Activities of Daptomycin, Linezolid, and Tigecycline against Catheter-Related Methicillin-Resistant Staphylococcus Bacteremic Isolates Embedded in Biofilm. Antimicrob. Agents Chemother. 51: 1656-1660 [Abstract] [Full Text]  
  • Aslam, S., Trautner, B. W., Ramanathan, V., Darouiche, R. O. (2007). Combination of Tigecycline and N-Acetylcysteine Reduces Biofilm-Embedded Bacteria on Vascular Catheters. Antimicrob. Agents Chemother. 51: 1556-1558 [Abstract] [Full Text]  
  • Olson, M. W., Ruzin, A., Feyfant, E., Rush, T. S. III, O'Connell, J., Bradford, P. A. (2006). Functional, biophysical, and structural bases for antibacterial activity of tigecycline.. Antimicrob. Agents Chemother. 50: 2156-2166 [Abstract] [Full Text]  
  • Giacometti, A., Cirioni, O., Ghiselli, R., Orlando, F., Mocchegiani, F., Silvestri, C., Licci, A., De Fusco, M., Provinciali, M., Saba, V., Scalise, G. (2005). Comparative Efficacies of Quinupristin-Dalfopristin, Linezolid, Vancomycin, and Ciprofloxacin in Treatment, Using the Antibiotic-Lock Technique, of Experimental Catheter-Related Infection Due to Staphylococcus aureus. Antimicrob. Agents Chemother. 49: 4042-4045 [Abstract] [Full Text]  
  • Pankey, G. A. (2005). Tigecycline. J Antimicrob Chemother 56: 470-480 [Abstract] [Full Text]  
  • Pettit, R. K., Weber, C. A., Kean, M. J., Hoffmann, H., Pettit, G. R., Tan, R., Franks, K. S., Horton, M. L. (2005). Microplate Alamar Blue Assay for Staphylococcus epidermidis Biofilm Susceptibility Testing. Antimicrob. Agents Chemother. 49: 2612-2617 [Abstract] [Full Text]  
  • Sun, H. K., Ong, C. T., Umer, A., Harper, D., Troy, S., Nightingale, C. H., Nicolau, D. P. (2005). Pharmacokinetic Profile of Tigecycline in Serum and Skin Blister Fluid of Healthy Subjects after Multiple Intravenous Administrations. Antimicrob. Agents Chemother. 49: 1629-1632 [Abstract] [Full Text]